Wednesday, March 29, 2017
Company News: Page (1) of 1 - 08/05/11 Email this story to a friend. email article Print this page (Article printing at page facebook
BioPlus Now Part of the Blue Cross and Blue Shield of North Carolina Specialty Pharmacy Network
(August 05, 2011)

Altamonte Springs, FL (PRWEB) August 05, 2011

Blue Cross and Blue Shield of North Carolina has made BioPlus Specialty Pharmacy part of their specialty pharmacy network. Specialty pharmacies provide access to high cost medications needed for conditions such as arthritis, hepatitis C, cancer, hemophilia, and other chronic diseases. Typically, access to these types of medications is limited and not usually available at local drug stores.

Our mission of measurably improving outcomes gives us a guideline to provide cost effective management solutions for patients, payers, and physicians, states Dr. Stephen Vogt, president and CEO of BioPlus.

BioPlus not only provides access to these drugs, but also works on educating the patients, which has led to improved drug adherence and a better quality of life for patients. Our partnership with the physician touches the life of a patient in ways that mail-order simply cannot, notes Dr. Vogt. The latest compliance statistics, based on more than 19,700 BioPlus patients being treated for hepatitis C, oncology, rheumatoid arthritis, psoriasis, Crohns disease, and other conditions, show that BioPlus achieves a 91 percent compliance rate at discharge. The compliance rate for retail and mail-order pharmacies is only 50 percent.

BioPlus provides comprehensive training by a registered pharmacist and provides 24/7 phone access to pharmacists including nights, weekends, and holidays. As families are faced with confusing choices of their benefits and increases in their premiums and co-pays, it is a win for beneficiaries to get our value added services, states Dr. Vogt. We dont use phone-trees, we coordinate care with the physician and insurance plan as we have for over 20 years.

About BioPlus Specialty Pharmacy

BioPlus is a pharmacist-owned, VIPPS accredited, national specialty infusion pharmacy providing high-touch services and specialty pharmaceuticals for patients with chronic diseases such as arthritis, hepatitis C, cancer, and other conditions. Licensed in all 50 states, BioPlus is one of the nations largest independent specialty pharmacies. Accredited by the Community Health Accreditation Program (CHAP), patients can contact the Pharmacy toll free at 1-888-292-0744.

For information: or
Contact: info(at)bioplusrx(dot)com
Phone: 1-800-566-6103

# # #

Read the full story at

Page: 1

Related Keywords:cancer, medical procedure/test, medical research, medical staff, medical specialisation, medical service, medical conditions, medical procedure/test, medical research, medical staff, medicine, preventative medicine, medical specialisation, medical service, medical conditions, family, family planning, medical procedure/test, medical research, medical staff, medical specialisation, medical service, medical conditions, , market research, research and development, medical procedure/test, medical research,
Related Sites:
Related Newsletter:

  • More Evidence of the Link Between Gum Disease and Diabetes Points Out the Systemic Importance of Good Oral Health, says Dr. Peiman Soleymani
  • Interventional Radiology Market Growing at a CAGR of 6.7% During 2016 to 2021 - ReportsnReports
  • Dr. Natalie Geary selected as "Top Pediatrician of the Year" for 2017 by the International Association of Top Professionals (IAOTP).
  • Audiology Devices Market is Expected to Reach USD 12,715.3 Mn by 2023 - Credence Research
  • Global $20.99 Billion Ablation Devices Market 2017-2023: Oncology is Holding the Largest Revenue in 2016

  • COA Completely Disagrees with Draft MedPAC Medicare Part B Recommendations
  • Two South Florida Medical Facilities Choose Air Esscentials to Implement Innovative Hospital Environmental Scenting Programs
  • Ablation Devices Global Market - Forecast to 2023 - Improving Reimbursement Scenario in Established Markets is a Key Market Driver - Research and Markets
  • BioDuro launches humanized tumor microenvironment, three-dimensional drug screening and patient-derived xenograft verification platform: hTME-3DX Screen and Verify
  • Liquid Biopsies That Can Screen and Detect Cancer Early Winning Over Investors

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines